Desk · Pharma
Pharma leadership seats, before the search starts.
Reorganizations, separations, new franchises and new US plants keep pharma leadership moving. This desk shows your partners which US, business unit, function and site seats are about to open, and who will make the hire.
Who we cover
Global, mid-size and specialty pharma, generics and biosimilars, animal health, and the US businesses of non-US companies, including their US manufacturing sites.
The seats
CEO and president, US president or country head, COO, CFO, chief commercial officer, chief medical officer, head of R&D, chief technical or manufacturing officer, chief quality officer, chief business or strategy officer, general counsel, chief people officer, CIO and chief compliance officer; business unit, franchise and therapeutic area heads, VPs in medical affairs, market access, regulatory, quality, supply chain and commercial operations, major site heads and independent directors.
What opens them
Who usually decides
The board chair for the CEO. The global CEO or regional head for a US president. The commercial or R&D head for a business unit or therapeutic area head. The head of manufacturing for a site head.
- A leader leaves, retires or is promoted, with no successor named.
- A company reorganizes, spins off a business or completes an acquisition.
- A first approval in a therapeutic area new to the company.
- A product deal takes the company into a new area or territory.
- A new US plant or a new manufacturing capability.
- A non-US company names its first US leader.
- An FDA warning letter or consent decree at a US site.
See who's about to hire on your desk.
FAQ
What happens to leadership when a pharma company spins off a business?
The new company usually names its CEO and CFO first, then fills the rest of its senior team and board before it becomes independent. Seats at the parent open as leaders move across.
Other desks:Hospitals and health systems · Post-acute and long-term care · Outpatient and specialty care · Academic medicine · Biotech · MedTech and diagnostics · CDMO and CRO